Atlas Trials

Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome

Clinical trial NCT07043322 · RECRUITING

Trial details

NCT number
NCT07043322
Sponsor
Tanta University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Gynecologic Disease
Start date
2025-06-30
Primary completion
2026-10-20
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.